The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

Patients with psoriasis without musculoskeletal involvement are 2.5 times more likely to have synovitis on imaging than control patients.

The prevalence of drinking alcohol in the US has declined in recent years while belief that drinking is unhealthy has increased.

The management of infantile hemangioma has changed in recent years, shifting from an observation-based approach to active treatment in most patients.

New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.

ESK-001, a novel therapy for moderate to severe plaque psoriasis, had acceptable safety and efficacy outcomes at 12 weeks of treatment.

Clinician documentation concerning patient credibility disproportionately undermined Black individuals vs patients of other races.

Researchers have identified an association between varicose veins and central serous chorioretinopathy and serous pigment ...

Topline results were announced from a phase 3 trial evaluating Cylembio (imsapepimut and etimupepimut, adjuvanted) in combination with pembrolizumab as a first-line treatment for advanced melanoma.

Wait times for a bed exceeding 4 hours occurred in 25% of admissions from the emergency room in nonpeak months.

Patients with dermally-based leiomyosarcoma generally have a better prognosis than patients with subcutis-based leiomyosarcoma.